Cryosite Ltd
Cryosite Limited is engaged in providing outsourced clinical trials depot services.
The business
Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Ambient, Cold, and Frozen, Ultra Frozen and Cryogenic and Cord blood. The Ambient, Cold, and Frozen segment storages and distributes small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions. Ultra Frozen and Cryogenic is engaged in specialized handling of materials requiring Ultra-Frozen or Cryogenic conditions, including Advanced Therapy Medicinal Products (ATMPs), such as Cell and Gene Therapies (CGT), cell therapies, and others. The cord blood segment is engaged in storage of cord blood cell and tissue samples for personal or directed therapeutic use, maintained under validated chain-of-identity controls.
Small Caps Research
No research on Cryosite Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise CTE based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.